Firefly Neuroscience is an AI-powered precision neuroscience company that provides the FDA-cleared Evoke System, a point-of-care hardware and software platform for standardized electroencephalographic and event-related potential assessments. The system captures brain and heart activity data that is analyzed by a proprietary cloud-based analytics engine and compared against a large proprietary database of assessment records, generating clinician-ready reports to support diagnostic decision-making and treatment monitoring across neurological and psychiatric conditions. The company generates revenue through tiered monthly subscription fees for access to the Evoke System and analytics platform, per-scan overage charges, and licensing its electrophysiological database and biomarker capabilities to pharmaceutical and research organizations for drug development programs.